EGFR and head and neck squamous cell carcinoma: The EGFR-K521 (K-allele), resulting from a single nucleotide polymorphism which involves the EGFR ECD, has been found in 56% of HNSCC patients and shown to display a reduced affinity for Cetuximab (60).